Milestone Pharmaceuticals Inc.
NASDAQ:MISTBiotechnology
-$0.00 today
- Market cap
- $57.32M
- Beta
- 0.96
- P/E (TTM)
- -2.5
- EPS (TTM)
- -$0.52
Volume 2.23M
Average 1.99M
Balance Sheet
Inspect the capital base behind the business.
Assets
$113.56M
FY 2025 · Annual
+50.4% YoYLiabilities
$71.79M
FY 2025 · Annual
+15.1% YoYEquity
$41.77M
FY 2025 · Annual
+217.7% YoYBalance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 114.14M | 7.64M | 13.76M | 25.31M | 73.05M |
| Short-term Investments | 0 | 56.95M | 52.24M | 44.38M | 32.91M |
| Net Receivables | 483K | 1.21M | 3.85M | 2.39M | 3.51M |
| Inventory | 0 | 0 | 0 | 0 | 648K |
| Other Current Assets | 0 | 0 | 0 | 0 | 0 |
| Total Current Assets | 118.92M | 71.8M | 73.03M | 73.93M | 111.92M |
| Property, Plant & Equipment (Net) | 926K | 2.68M | 2.19M | 1.57M | 1.64M |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 |
| Long-term Investments | 0 | 0 | 0 | 0 | 0 |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 0 | 0 | 0 | 0 | 0 |
| Total Non-current Assets | 926K | 2.68M | 2.19M | 1.57M | 1.64M |
| Total Assets | 119.85M | 74.48M | 75.23M | 75.5M | 113.56M |
| Account Payables | 4.38M | 2.26M | 3.98M | 1.93M | 5.65M |
| Short-term Debt | 224K | 495K | 0 | 0 | 647K |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 709K | 808K | 1.99M | (0) | 5.23M |
| Total Current Liabilities | 6.78M | 6.14M | 7.23M | 8.13M | 13.98M |
| Long-term Debt | 0 | 0 | 49.77M | 53.35M | 57.19M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 0 | 0 | 0 | 0 | 83K |
| Total Non-current Liabilities | 474K | 2M | 51.23M | 54.23M | 57.81M |
| Total Liabilities | 7.25M | 8.14M | 58.46M | 62.35M | 71.79M |
| Common Stock | 251.9M | 273.9M | 260.5M | 288.05M | 352.62M |
| Retained Earnings | (206.32M) | (266.34M) | (326.03M) | (367.55M) | (430.6M) |
| Accumulated OCI | 51.31M | 34.35M | 48.46M | 53.08M | 55.65M |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 112.6M | 66.35M | 16.77M | 13.15M | 41.77M |
| Total Debt | 698K | 2.49M | 51.78M | 54.8M | 58.38M |
| Net Debt | (113.44M) | (5.15M) | 38.02M | 29.48M | (14.67M) |
Balance Sheet
Assets, liabilities & equity
| Cash & Equivalents | $71.3M |
| Short-term Investments | $112.9M |
| Receivables | $5.0M |
| Inventory | $1.8M |
| Other Current | $1.2M |
| Total Current Assets | $192.3M |
| PP&E (Net) | $1.5M |
| Total Non-current Assets | $1.5M |
| Total Assets | $193.7M |
Analysis
Selected assets total $193.7M for Latest. The largest visible component is Short-term Investments at $112.9M, about 58.3% of the tab total. Use the mix to judge balance sheet concentration, liquidity, leverage, and how much of book value is supported by tangible operating assets.
Recent Filings
Recent regulatory filings
| Filing | Description | Date | |
|---|---|---|---|
| 10-Q | Quarterly report | Nov 13, 2026 | |
| 8-K | Current report | Nov 13, 2026 | |
| 8-K | Current report | Oct 28, 2026 | |
| 8-K | Current report | Sep 3, 2026 | |
| 8-K | Current report | Aug 12, 2026 |
How much cash does MIST have?
Milestone Pharmaceuticals Inc. (MIST) reported $73.05M in cash and equivalents in fiscal 2025.
How much debt does MIST carry?
Milestone Pharmaceuticals Inc. (MIST) reported $58.38M of total debt, with net debt of -$14.67M.
Continue the stock analysis
Jump to another research area for this company.